StreetInsider
Log in to your account:
Log in
Signup
Home
EPS Insider
Event Calendar
Conferences
Classic Site
Upgrade to SI Premium - Free Trial
Dyne Therapeutics (DYN) PT Raised to $47 at Piper Sandler
July 20, 2026 11:29 AM
Piper Sandler analyst Edward Tenthoff ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
Categories
Analyst PT Change